Latest VRTX Analyst Ratings & Recommendations
Recent analyst recommendations with rating changes and price target updates (last 90 days)
| Date | Analyst | Firm | Action | Rating | Price Target |
|---|---|---|---|---|---|
| David Jagielski, CPA | The Motley Fool | Initiates Coverage | Buy | - | |
| Danielle Brill | Truist | Maintains | Buy | $542.00 → $560.00 +18.00 (3.3%) | |
| Tazeen Ahmad | BofA Securities | Reiterates | Buy | $598.00 → $600.00 +2.00 (0.3%) | |
| Evan Seigerman | BMO Capital | Maintains | Buy | $600.00 | |
| Michael Yee | UBS | Reiterates | Buy | $545.00 → $585.00 +40.00 (7.3%) | |
| Mohit Bansal | Wells Fargo | Maintains | Buy | $550.00 | |
| Naz Rahman | Maxim | Reiterates | Buy | $575.00 | |
| Google Biotechnology | TipRanks - Google | Reiterates | Buy | $607.00 → $617.00 +10.00 (1.6%) | |
| PerPlexity Biotechnology | TipRanks - PerPlexity | Reiterates | Buy | $620.00 | |
| Anthropic Biotechnology | TipRanks - Anthropic | Downgrades | Buy | $578.00 → $585.00 +7.00 (1.2%) | |
| OpenAI Biotechnology | TipRanks - OpenAI | Reiterates | Buy | $599.00 → $609.00 +10.00 (1.7%) | |
| UK | Investing.com | Initiates Coverage | Buy | - | |
| Akash Tewari | Jefferies | Maintains | Buy | $610.00 | |
| Eliana Merle | Barclays | Maintains | Buy | $615.00 | |
| Evan Seigerman | BMO Capital | Maintains | Buy | $600.00 | |
| Whitney Ijem | Canaccord Genuity | Maintains | Hold | $436.00 | |
| Louise Chen | Scotiabank | Maintains | Buy | $558.00 | |
| Andrew Fein | HC Wainwright | Maintains | Buy | $641.00 | |
| Myles Minter | William Blair | Maintains | Buy | - | |
| Danielle Brill | Truist | Maintains | Buy | - | |
| Phil Nadeau | TD Cowen | Maintains | Buy | $525.00 | |
| Geoff Meacham | Citi | Maintains | Buy | $585.00 | |
| Brian Skorney | Baird | Maintains | Sell | $330.00 → $350.00 +20.00 (6.1%) | |
| Joseph Stringer | Needham | Maintains | Hold | - | |
| Brian Abrahams | RBC Capital | Maintains | Buy | $543.00 → $570.00 +27.00 (5.0%) | |
| Cory Kasimov | Evercore ISI Group | Maintains | Buy | $535.00 | |
| Whitney Ijem | Canaccord Genuity | Maintains | Hold | $436.00 | |
| Carter Gould | Cantor Fitzgerald | Maintains | Buy | $590.00 | |
| Salveen Richter | Goldman Sachs | Maintains | Buy | $641.00 | |
| Mohit Bansal | Wells Fargo | Maintains | Buy | $550.00 | |
| Brian Abrahams | RBC Capital | Reiterates | Buy | $543.00 | |
| Naz Rahman | Maxim | Reiterates | Buy | $575.00 | |
| Unknown Analyst | Guggenheim | Maintains | Buy | $546.00 | |
| Danielle Brill | Truist | Initiates | Buy | $525.00 → $542.00 +17.00 (3.2%) | |
| Unknown Analyst | JP Morgan | Maintains | Buy | $515.00 | |
| Google Biotechnology | TipRanks - Google | Reiterates | Buy | $481.00 → $516.00 +35.00 (7.3%) | |
| PerPlexity Biotechnology | TipRanks - PerPlexity | Reiterates | Buy | $496.00 → $527.00 +31.00 (6.3%) | |
| Anthropic Biotechnology | TipRanks - Anthropic | Reiterates | Hold | $466.00 → $491.00 +25.00 (5.4%) | |
| OpenAI Biotechnology | TipRanks - OpenAI | Reiterates | Buy | $486.00 → $509.00 +23.00 (4.7%) | |
| Eliana Merle | Barclays | Maintains | Buy | $607.00 → $615.00 +8.00 (1.3%) | |
| Paul Matteis | Stifel Nicolaus | Maintains | Hold | $466.00 | |
| Whitney Ijem | Canaccord Genuity | Maintains | Hold | $437.00 → $436.00 -1.00 (-0.2%) | |
| Louise Chen | Scotiabank | Maintains | Buy | $558.00 | |
| Hans Engel | Erste | Maintains | Hold | - | |
| Andrew Fein | HC Wainwright | Maintains | Buy | $547.00 → $641.00 +94.00 (17.2%) | |
| Myles Minter | William Blair | Reiterates | Buy | - | |
| William Pickering | Bernstein | Maintains | Buy | $577.00 → $572.00 -5.00 (-0.9%) | |
| Phil Nadeau | TD Cowen | Maintains | Buy | $525.00 | |
| Jay Olson | Oppenheimer | Maintains | Buy | $600.00 | |
| Joseph Stringer | Needham | Reiterates | Hold | - | |
| Cory Kasimov | Evercore ISI Group | Maintains | Buy | $530.00 → $535.00 +5.00 (0.9%) | |
| Terence Flynn | Morgan Stanley | Initiates Coverage | Buy | $612.00 → $616.00 +4.00 (0.7%) | |
| Andrew Fein | HC Wainwright | Maintains | Buy | $547.00 → $641.00 +94.00 (17.2%) | |
| Evan Seigerman | BMO Capital | Maintains | Buy | $600.00 |
